Viking Therapeutics (VKTX) Misses Q2 EPS by 13c

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Golden Spike Resources plans name change, share consolidation and C$500K raise
• Wendy's U.S. president to resign, company to create COO role